• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶激活受体在肠道通透性调节中的信号转导。

Protease-activated receptor signaling in intestinal permeability regulation.

机构信息

Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Johannes Gutenberg University of Mainz, Germany.

Centro de Apoio Tecnológico Agro Alimentar (CATAA), Zona Industrial de Castelo Branco, Portugal.

出版信息

FEBS J. 2020 Feb;287(4):645-658. doi: 10.1111/febs.15055. Epub 2019 Sep 23.

DOI:10.1111/febs.15055
PMID:31495063
Abstract

Protease-activated receptors (PARs) are a unique class of G-protein-coupled transmembrane receptors, which revolutionized the perception of proteases from degradative enzymes to context-specific signaling factors. Although PARs are traditionally known to affect several vascular responses, recent investigations have started to pinpoint the functional role of PAR signaling in the gastrointestinal (GI) tract. This organ is exposed to the highest number of proteases, either from the gut lumen or from the mucosa. Luminal proteases include the host's digestive enzymes and the proteases released by the commensal microbiota, while mucosal proteases entail extravascular clotting factors and the enzymes released from resident and infiltrating immune cells. Active proteases and, in case of a disrupted gut barrier, even entire microorganisms are capable to translocate the intestinal epithelium, particularly under inflammatory conditions. Especially PAR-1 and PAR-2, expressed throughout the GI tract, impact gut permeability regulation, a major factor affecting intestinal physiology and metabolic inflammation. In addition, PARs are critically involved in the onset of inflammatory bowel diseases, irritable bowel syndrome, and tumor progression. Due to the number of proteases involved and the multiple cell types affected, selective regulation of intestinal PARs represents an interesting therapeutic strategy. The analysis of tissue/cell-specific knockout animal models will be of crucial importance to unravel the intrinsic complexity of this signaling network. Here, we provide an overview on the implication of PARs in intestinal permeability regulation under physiologic and disease conditions.

摘要

蛋白酶激活受体(PARs)是一类独特的 G 蛋白偶联跨膜受体,它们彻底改变了人们对蛋白酶的认识,使其从降解酶转变为具有特定作用的信号因子。尽管 PARs 传统上被认为会影响多种血管反应,但最近的研究开始确定 PAR 信号在胃肠道(GI)中的功能作用。该器官暴露于数量最多的蛋白酶,这些蛋白酶来自肠腔或黏膜。肠腔蛋白酶包括宿主的消化酶和共生微生物群释放的蛋白酶,而黏膜蛋白酶涉及血管外凝血因子以及驻留和浸润免疫细胞释放的酶。活性蛋白酶,甚至在肠道屏障被破坏的情况下,整个微生物都能够穿过肠上皮细胞,尤其是在炎症条件下。特别是在整个胃肠道表达的 PAR-1 和 PAR-2,影响肠道通透性调节,这是影响肠道生理学和代谢炎症的主要因素。此外,PARs 还与炎症性肠病、肠易激综合征和肿瘤进展密切相关。由于涉及的蛋白酶数量众多,以及受影响的多种细胞类型,选择性调节肠道 PARs 是一种很有前途的治疗策略。分析组织/细胞特异性基因敲除动物模型对于揭示该信号网络的内在复杂性至关重要。在这里,我们概述了 PARs 在生理和疾病条件下对肠道通透性调节的影响。

相似文献

1
Protease-activated receptor signaling in intestinal permeability regulation.蛋白酶激活受体在肠道通透性调节中的信号转导。
FEBS J. 2020 Feb;287(4):645-658. doi: 10.1111/febs.15055. Epub 2019 Sep 23.
2
Protease-activated receptors: protease signaling in the gastrointestinal tract.蛋白酶激活受体:胃肠道中的蛋白酶信号传导
Curr Opin Pharmacol. 2004 Dec;4(6):551-6. doi: 10.1016/j.coph.2004.08.004.
3
Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases.炎症性肠病和肠易激综合征中的内脏高敏感性:蛋白酶的作用。
World J Gastroenterol. 2016 Dec 21;22(47):10275-10286. doi: 10.3748/wjg.v22.i47.10275.
4
Protease activated receptor 2: a new target for IBS treatment.蛋白酶激活受体2:肠易激综合征治疗的新靶点。
Eur Rev Med Pharmacol Sci. 2008 Aug;12 Suppl 1:95-102.
5
Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications.炎症性肠病中的肠内细菌蛋白酶 - 病理生理学和临床意义。
World J Gastroenterol. 2013;19(43):7531-43. doi: 10.3748/wjg.v19.i43.7531.
6
Mechanisms of disease: protease functions in intestinal mucosal pathobiology.疾病机制:蛋白酶在肠道黏膜病理生物学中的作用
Nat Clin Pract Gastroenterol Hepatol. 2007 Jul;4(7):393-402. doi: 10.1038/ncpgasthep0846.
7
Regulation of intestinal permeability: The role of proteases.肠道通透性的调节:蛋白酶的作用。
World J Gastroenterol. 2017 Mar 28;23(12):2106-2123. doi: 10.3748/wjg.v23.i12.2106.
8
The emerging roles of bacterial proteases in intestinal diseases.细菌蛋白酶在肠道疾病中的新兴作用。
Gut Microbes. 2023 Jan-Dec;15(1):2181922. doi: 10.1080/19490976.2023.2181922.
9
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.用于研究正常和炎症状态下人结肠上皮细胞代谢与免疫功能的体外模型的开发、验证及应用
Dan Med J. 2015 Jan;62(1):B4973.
10
Protease-activated receptors: potential therapeutic targets in irritable bowel syndrome?蛋白酶激活受体:肠易激综合征潜在的治疗靶点?
Expert Opin Ther Targets. 2005 Oct;9(5):1079-95. doi: 10.1517/14728222.9.5.1079.

引用本文的文献

1
HapA protease targets PAR-1/2 to modulate ERK signalling and reduce cancer cell viability.HapA蛋白酶作用于PAR-1/2以调节ERK信号传导并降低癌细胞活力。
Cell Death Discov. 2025 Aug 28;11(1):415. doi: 10.1038/s41420-025-02691-7.
2
A pathophysiologic framework for the overlap of disorders of gut-brain interaction and the role of the gut microbiome.用于肠-脑相互作用障碍重叠的病理生理框架和肠道微生物组的作用。
Gut Microbes. 2024 Jan-Dec;16(1):2413367. doi: 10.1080/19490976.2024.2413367. Epub 2024 Oct 31.
3
Unlocking the therapeutic potential of Huoxiang Zhengqi San in cold and high humidity-induced diarrhea: Insights into intestinal microbiota modulation and digestive enzyme activity.
揭示藿香正气散在寒冷和高湿度诱发腹泻中的治疗潜力:对肠道微生物群调节和消化酶活性的见解
Heliyon. 2024 Jun 12;10(12):e32789. doi: 10.1016/j.heliyon.2024.e32789. eCollection 2024 Jun 30.
4
Protective role of protease-activated receptor-2 in anaphylaxis model mice.蛋白酶激活受体-2 在过敏反应模型小鼠中的保护作用。
PLoS One. 2024 Apr 18;19(4):e0283915. doi: 10.1371/journal.pone.0283915. eCollection 2024.
5
Single nuclear RNA sequencing of terminal ileum in patients with cirrhosis demonstrates multi-faceted alterations in the intestinal barrier.肝硬化患者回肠末端的单核RNA测序显示肠道屏障存在多方面改变。
Cell Biosci. 2024 Feb 19;14(1):25. doi: 10.1186/s13578-024-01209-5.
6
Inhibition of proteinase-activated receptor 2 (PAR2) decreased the malignant progression of lung cancer cells and increased the sensitivity to chemotherapy.蛋白酶激活受体2(PAR2)的抑制作用降低了肺癌细胞的恶性进展,并增加了对化疗的敏感性。
Cancer Chemother Pharmacol. 2024 May;93(5):397-410. doi: 10.1007/s00280-023-04630-8. Epub 2024 Jan 4.
7
Protease-Activated Receptor 1-Mediated Damage of Podocytes in Diabetic Nephropathy.蛋白酶激活受体 1 介导的糖尿病肾病足细胞损伤。
Diabetes. 2023 Dec 1;72(12):1795-1808. doi: 10.2337/db23-0032.
8
A Brief History of Glandular Therapy: More Than Just Thyroid.腺体疗法简史:不止于甲状腺。
Integr Med (Encinitas). 2023 May;22(2):26-31.
9
Changes in Protease-Activated Receptor and Trypsin-1 Expression Are Involved in the Therapeutic Effect of Mg Supplementation in Type 2 Diabetes-Induced Gastric Injury in Male Adult Rats.蛋白酶激活受体和胰蛋白酶-1表达的变化与镁补充对成年雄性大鼠2型糖尿病诱导的胃损伤的治疗作用有关。
Adv Pharmacol Pharm Sci. 2023 May 16;2023:5703718. doi: 10.1155/2023/5703718. eCollection 2023.
10
Regulation of Physiological Barrier Function by the Commensal Microbiota.共生微生物群对生理屏障功能的调节
Life (Basel). 2023 Jan 31;13(2):396. doi: 10.3390/life13020396.